These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 3545527

  • 1. Marked differences between mutagenicity in Salmonella and tumour-initiating activities of dibenzo[a,e]fluoranthene proximate metabolites; initiation inhibiting activity of norharman.
    Zajdela F, Perin-Roussel O, Saguem S.
    Carcinogenesis; 1987 Mar; 8(3):461-4. PubMed ID: 3545527
    [Abstract] [Full Text] [Related]

  • 2. 32P-postlabeling analysis of inhibition by norharman of formation of dibenzo[a,e]fluoranthene--DNA adducts in mouse embryo fibroblasts.
    Périn-Roussel O, Périn F, Barat N, Zajdela F.
    Carcinogenesis; 1992 Apr; 13(4):723-5. PubMed ID: 1576724
    [Abstract] [Full Text] [Related]

  • 3. Apparent stimulation of dibenzo[a,e]fluoranthene in vitro metabolism in the presence of norharman.
    Perin-Roussel O, Ekert B, Zajdela F.
    Chem Biol Interact; 1981 Oct; 37(1-2):109-22. PubMed ID: 6169460
    [Abstract] [Full Text] [Related]

  • 4. Possible involvement of a vicinal, non-bay-region dihydrodiol-epoxide in the activation of dibenzo[a,e]fluoranthene into bacterial mutagens.
    Malaveille C, Hautefeuille A, Perin-Roussel O, Saguem S, Croisy-Delcey M, Zajdela F, Bartsch H.
    Carcinogenesis; 1984 Oct; 5(10):1263-6. PubMed ID: 6386214
    [Abstract] [Full Text] [Related]

  • 5. 32P-post-labeling analysis of DNA adducts in mouse embryo fibroblasts treated with dibenzo[a,e]fluoranthene and its major metabolites.
    Périn-Roussel O, Périn F, Zajdela F.
    Carcinogenesis; 1990 Feb; 11(2):301-6. PubMed ID: 2302757
    [Abstract] [Full Text] [Related]

  • 6. Differences in metabolic activation of dibenzo[a,e]fluoranthene characterized by 32P-postlabeling in two mouse fibroblast models.
    Périn-Roussel O, Barat N, Plessis MJ, Zajdela F.
    Cancer Lett; 1992 Jan 31; 61(3):207-13. PubMed ID: 1739945
    [Abstract] [Full Text] [Related]

  • 7. Mutagenicity and tumor initiating activity of methylated benzo[b]fluoranthenes.
    Amin S, Huie K, Hecht SS.
    Carcinogenesis; 1985 Jul 31; 6(7):1023-5. PubMed ID: 3893781
    [Abstract] [Full Text] [Related]

  • 8. Formation and persistence of DNA-protein cross-links induced in mouse fibroblasts by dibenzo[a,e]fluoranthene, and modulation by stimulators and inhibitors of polycyclic aromatic hydrocarbons (PAH) metabolism.
    Perin-Roussel O, Barat N, Zajdela F.
    Cancer Lett; 1987 Aug 31; 36(2):169-80. PubMed ID: 3621149
    [Abstract] [Full Text] [Related]

  • 9. Multi-step metabolism of the carcinogen dibenzo[a,e]fluoranthene. II. Metabolic pathways.
    Saguem S, Perin-Roussel O, Mispelter J, Lhoste JM, Zajdela F.
    Carcinogenesis; 1983 Aug 31; 4(7):837-42. PubMed ID: 6872138
    [Abstract] [Full Text] [Related]

  • 10. Co-mutagenic effect of norharman with N-nitrosamine derivatives.
    Wakabayashi K, Nagao M, Kawachi T, Sugimura T.
    Mutat Res; 1981 Jan 31; 80(1):1-7. PubMed ID: 7010130
    [Abstract] [Full Text] [Related]

  • 11. Effect of fluorine substitution on benzo[j]fluoranthene genotoxicity.
    Weyand EH, He ZM, Ghodrati F, Wu Y, Marshall MV, LaVoie EJ.
    Chem Biol Interact; 1992 Sep 14; 84(1):37-53. PubMed ID: 1394615
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the in vitro metabolisms and mutagenicities of dibenzo[a,c]anthracene, dibenzo[a,h]anthracene and dibenzo[a,j]anthracene: influence of norharman.
    Lecoq S, Perin F, Plessis MJ, Strapelias H, Duquesne M.
    Carcinogenesis; 1989 Mar 14; 10(3):461-9. PubMed ID: 2924394
    [Abstract] [Full Text] [Related]

  • 13. Formation and removal of dibenzo[a,e]fluoranthene-DNA adducts in mouse embryo fibroblasts.
    Périn-Roussel O, Barat N, Zajdela F.
    Carcinogenesis; 1985 Dec 14; 6(12):1791-6. PubMed ID: 4064254
    [Abstract] [Full Text] [Related]

  • 14. Harman and norharman induce SOS responses and frameshift mutations in bacteria.
    Oda Y, Nakamura S, Oki I.
    Mutat Res; 1988 May 14; 208(1):39-44. PubMed ID: 3285203
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comutagenic effect of norharman with aminopyridine derivatives.
    Wakabayashi K, Yahagi T, Nagao M, Sugimura T.
    Mutat Res; 1982 Oct 14; 105(4):205-10. PubMed ID: 7133029
    [Abstract] [Full Text] [Related]

  • 20. Mutagenicity and tumor initiating activity of methylated benzo[k] fluoranthenes.
    Amin S, Hussain N, Balanikas G, Huie K, Hecht SS.
    Cancer Lett; 1985 Apr 14; 26(3):343-7. PubMed ID: 3995506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.